Home/Protega Pharmaceuticals/Hafid Touam

HT

Hafid Touam

Chief Business Officer

Protega Pharmaceuticals

Therapeutic Areas

Pain Management Opioid Use Disorder

Protega Pharmaceuticals Pipeline

Drug	Indication	Phase
SentryBond-based Opioid Products	Pain Management (with abuse-deterrent properties)	Pre-clinical

Leadership Team at Protega Pharmaceuticals

Stefan Aigner, MD, CFA

Chairman and Chief Executive Officer

View full Protega Pharmaceuticals profile